Jim Tananbaum

Founder and CEO of @foresitecapital, healthcare venture capital firm.

[Jim Tananbaum @JTananbaum]

Thank you to @FierceBiotech for their coverage of our new fund, announced today. It's an exciting time to be a biotech investor, and we look forward to continuing our support of the entrepreneurs who are making a difference. https://t.co/MTObArSE7X

[Jim Tananbaum @JTananbaum]

A new cohort of #VCUniversity starts tomorrow through @VCForward, with this amazing group of scholarship recipients in the life sciences track who will be reshaping our industry in years to come. My firm @ForesiteCapital is proud to continue our support of this program.

[Venture Forward @VCForward]

#VCUniversity Cohort 13 kicks off tomorrow! 🎉 We’re proud to have awarded full scholarships to the course for 40 new and aspiring VCs. Get to know them. 👉

[Jim Tananbaum @JTananbaum]

Great news for the team at XinThera with their acquisition by @GileadSciences announced today. @ForesiteCapital was the founding investor. Read my colleague's thoughts here: https://t.co/qdqwnb5MpJ

[Jim Tananbaum @JTananbaum]

I'm thrilled to have joined the @LACMA board to help foster appreciation for culture and creativity in Los Angeles and beyond. Read my thoughts here: https://t.co/ngMP3K9adW

[Jim Tananbaum @JTananbaum]

Congratulations to the team at @evonetix on this new funding round! We were excited to lead this investment to accelerate the company's commercial strategy and make gene synthesis more accessible.

[Jim Tananbaum @JTananbaum]

It was an honor to welcome attendees on Saturday at Yale's for Humanity Illuminated event at the Yerba Buena Center. So proud to partner with this team. The @Yale community is incredibly special, and it was an inspirational day.

[Jim Tananbaum @JTananbaum]

Please join my firm @ForesiteCapital in supporting this valuable program by volunteering as a life sciences peer mentor. The deadline is Friday.

[Venture Forward @VCForward]

VC Investors: Do you have 3-4 hours free to support a stronger, more diverse and inclusive ecosystem?

This is the last week to volunteer as a VC Mentor for Cohort 11 of the #VCUniversity Mentorship Program!

Learn more + sign up by this Friday, Sept. 30: https://t.co/oinzZrf1WR

[Jim Tananbaum @JTananbaum]

Congratulations to the scholarship recipients of Cohort 11 for the @VCForward life sciences track of #VCUniversity! We are so proud of our work with this program. These people are the future of the life science VC industry, and I can't wait to see what they accomplish.

[Venture Forward @VCForward]

Introducing #VCUniversity ONLINE’s Cohort 11 Scholarship Recipients!

Get to know these future leaders of the industry:
https://t.co/4pOSTFNHy7

[Jim Tananbaum @JTananbaum]

I'm proud to work with this team. Read our latest blog post from managing director Michael Rome.

[Foresite Capital @ForesiteCapital]

Our managing director Michael Rome shares his thoughts on the @Affinivax acquisition by @GSK in our latest blog post: https://t.co/GFJHTJXC2l

[Foresite Capital @ForesiteCapital]

Our managing director Michael Rome shares his thoughts on the @Affinivax acquisition by @GSK in our latest blog post: https://t.co/GFJHTJXC2l

[Jim Tananbaum @JTananbaum]

I'm proud to be supporting healthcare visionaries like Aaron.

[Foresite Capital @ForesiteCapital]

Congratulations to Aaron Ring from our portfolio company @Seranova Bio for his inclusion in this @endpts list of 20 under 40. "Everything is about momentum" -- we agree and we're thrilled to be working together.

[Jim Tananbaum @JTananbaum]

I'm excited to support the team at @ElemBio as they unveil their benchtop sequencer AVITI. I believe sequencing will touch all our lives. To enable it, we need high quality, inexpensive sequencing.

[Element Biosciences @ElemBio]

Hear @JTananbaum Element board member & Founder/CEO of @ForesiteCapital describe how AVITI enables a major shift in the sequencing market.

Register for our 3/14 virtual launch event to learn more: https://t.co/A08OUbd36s

#AviditySequencing #AVITI #NGS #Biotech #venturecapital

[Jim Tananbaum @JTananbaum]

This is a stellar group, and I'm proud that my firm is providing full scholarships to the life sciences track for these future leaders in our industry. Thank you to @VCForward and the @nvca.

[Venture Forward @VCForward]

Introducing #VCUniversity ONLINE’s Cohort 9 Scholarship Recipients!

Get to know these future leaders of the industry: https://t.co/p9ZauYHYJh

[Foresite Capital @ForesiteCapital]

Congratulations to the newest @ForesiteLabs incubated company, @tensixteenbio , for launching today! The company is the first to leverage CHIP to uncover the mysterious mutations in the blood and how they impact disease. Read more via @endpts here: https://t.co/CjYCUg2rJ0

[Jim Tananbaum @JTananbaum]

Welcoming ImmPACT Bio to our portfolio! Early clinical data is very promising in our view. We believe the efficacy & safety profile of the lead program will help expand access of CAR-T cell therapy to patients who have exhausted other options. Excited to work with this team!

[Endpoints News @endpts]

ImmPACT Bio unveiled a $111 million Series B round early Thursday morning, along with a C-suite shakeup and a first glimpse at some Phase I data.

https://t.co/iwqg98NqBg

[Jim Tananbaum @JTananbaum]

I'm very excited to announce the Tananbaum Center for Theoretical and Analytical Human Biology at @Yale led by @RMedzhitov to uncover fundamental knowledge about disease. Read about our new center here: https://t.co/VKXgGqZ0kz

[Jim Tananbaum @JTananbaum]

Great news out of @EikonTX yesterday, closing this round to help fuel their plans to analyze single molecule protein behavior in living cells. Their innovative tools and technologies for biological exploration will be used for drug discovery and beyond.

[TechCrunch @TechCrunch]

"How can you understand life if you don't look at it live?" — Eikon Therapeutics rakes in $518M https://t.co/oM9VNXheND by @emmakbetuel

[Jim Tananbaum @JTananbaum]

Proud to be working with Pardes Biosciences -- with FSII we are working to combat COVID-19 via an oral medicine that, if approved by regulatory authorities, could be used to treat and prevent the disease.
https://t.co/4opzXJXwaC

https://t.co/SvIc0zALYE

[Jim Tananbaum @JTananbaum]

Thank you @amyfeldman for this thoughtful coverage of our portfolio company @TassoInc, bringing blood testing into the home to improve access to care.

[Forbes @Forbes]

What if you could draw blood at home rather than having it done at the doctor’s office? That’s the premise of Seattle-based startup Tasso https://t.co/dyYCHC4rXF

[Jim Tananbaum @JTananbaum]

Really excited about this new initiative. Please help us spread the word to qualified applicants.

[Foresite Capital @ForesiteCapital]

Thrilled to introduce our new program – Foresite Fellows! This is a twelve-week part-time paid internship program, 8-10 hours/wk remotely for those enrolled in PhD, MD, MD/MBA, MD/PhD, or postdoc programs. Learn more and apply here:
https://t.co/rM5P8yoxPB